Search Within

Erica M. Gomes-Dagama

Formats
  1. Journal Article (8)
  2. Meeting Abstract (6)
  3. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (15)
  2. GSK Faculty (15)
  3. Hematologic Malignancies Research (15)
  4. Molecular Pharmacology and Chemistry Program Faculty (15)
  5. Sloan Kettering Institute Faculty (15)
  6. Sloan Kettering Institute Postdocs (13)

More Groups

People
  1. Gabriela Chiosis (15)
  2. Tony Taldone (13)
  3. Anna Rodina Balingcongan (9)
  4. Jason Lewis (8)
  5. Steven Larson (7)
  6. Hediye Erdjument-Bromage (6)

More People

Years
  1. 2016 (1)
  2. 2015 (4)
  3. 2014 (2)
  4. 2013 (4)
  5. 2012 (2)
  6. 2011 (2)
Publications
  1. Cancer Research (4)
  2. Journal of Clinical Oncology (2)
  3. ACS Chemical Biology (1)
  4. Beilstein Journal of Organic Chemistry (1)
  5. Bioorganic & Medicinal Chemistry Letters (1)
  6. Cell Death Signaling in Cancer Biology and Treatment (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Clinical Oncology (2)
  3. Nature Publishing Group (2)
  4. American Chemical Society (1)
  5. Beilstein Institute (1)
  6. Cell Press (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The epichaperome is an integrated chaperome network that facilitates tumour survival
    Journal Article

    Rodina, A.; Wang, T.; Yan, P.; Gomes, E. D.; Dunphy, M. P. S.; Pillarsetty, N.; Koren, J. 3rd; Gerecitano, J. F.; Taldone, T.; Zong, H.; more...
    Nature (2016)

    Fulltext@MSK | Save
  • A hyperactive signalosome in acute myeloid leukemia drives addiction to a tumor-specific Hsp90 species
    Journal Article

    Zong, H.; Gozman, A.; Caldas-Lopes, E.; Taldone, T.; Sturgill, E.; Brennan, S.; Ochiana, S. O.; Gomes-DaGama, E. M.; Sen, S.; Rodina, A.; more...
    Cell Reports (2015)

    Fulltext@MSK | Save
  • Development of a noninvasive assay to determine drug concentration in tumor during hsp90 inhibitor therapy
    Meeting Abstract

    Taldone, T.; Pillarsetty, N.; Dunphy, M. P. S.; Gerecitano, J. F.; Caldas-Lopes, E.; Beattie, B.; Peter, R. I.; Kang, Y. L.; Rodina, A.; Yan, P.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Development of chemical tools to study the endogenous Hsp70 interactome in malignant cells
    Meeting Abstract

    Rodina, A. A.; Taldone, T.; Kang, Y. L.; Patel, P.; Koren, J.; Yan, P.; DaGama Gomes, E.; Yang, C.; Patel, M.; Shrestha, L.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Affinity purification probes of potential use to investigate the endogenous Hsp70 interactome in cancer
    Journal Article

    Rodina, A.; Taldone, T.; Kang, Y.; Patel, P. D.; Koren, J.; Yan, P.; DaGama Gomes, E. M.; Yang, C.; Patel, M. R.; Shrestha, L.; more...
    ACS Chemical Biology (2014)

    Fulltext@MSK | Save
  • Heat shock protein 90 inhibitors in the treatment of cancer: Current status and future directions
    Journal Article

    Jhaveri, K.; Ochiana, S. O.; Dunphy, M. P. S.; Gerecitano, J. F.; Corben, A. D.; Peter, R. I.; Janjigian, Y. Y.; Gomes DaGama, E. M.; Koren, J. 3rd; Modi, S.; more...
    Expert Opinion on Investigational Drugs (2014)

    Fulltext@MSK | Save
  • Using (124)I-PU-H71 PET imaging to predict intratumoral concentration in patients on a phase I trial of PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Gajria, D.; Taldone, T.; Alpaugh, M.; DaGama, E. G.; Uddin, M.; Chiosis, G.; Lewis, J. S.; Larson, S. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Molecular chaperones and how addiction matters in cancer therapy
    Book Section

    Guzman, M. L.; Lowery, M. A.; Taldone, T.; Koren, J. 3rd; DaGama, E. G.; Chiosis, G.
    In Johnson, D. E. (Eds.) Cell Death Signaling in Cancer Biology and Treatment (2013)

    Fulltext@MSK | Save
  • Monitoring afatinib treatment in HER2-positive gastric cancer with (18)F-FDG and (89)Zr-trastuzumab PET
    Journal Article

    Janjigian, Y. Y.; Viola-Villegas, N.; Holland, J. P.; Divilov, V.; Carlin, S. D.; Gomes DaGama, E. M.; Chiosis, G.; Carbonetti, G.; de Stanchina, E.; Lewis, J. S.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save